Stockscreener 앱 받기
0.2077
2.61%
0.0044
전일 마감가:
$0.2033
열려 있는:
$0.2
하루 거래량:
1.19M
Relative Volume:
0.67
시가총액:
$17.92M
수익:
$1.78M
순이익/손실:
$-58.35M
주가수익비율:
-0.1266
EPS:
-1.64
순현금흐름:
$-56.66M
1주 성능:
+2.76%
1개월 성능:
-13.66%
6개월 성능:
-53.12%
1년 성능:
-83.95%
1일 변동 폭
$0.1965
$0.21
1주일 범위
$0.1905
$0.218
52주 변동 폭
$0.1905
$1.485
Beyond Air Inc Stock (XAIR) Company Profile
명칭
Beyond Air Inc
전화
516-665-8200
주소
900 STEWART AVENUE, GARDEN CITY, NY
XAIR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XAIR
Beyond Air Inc
|
0.2077 | 17.92M | 1.78M | -58.35M | -56.66M | -1.64 |
|
ABT
Abbott Laboratories
|
132.29 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.47 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.72 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.36 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.38 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Beyond Air Inc Stock (XAIR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-25 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-07-28 | 개시 | Piper Sandler | Overweight |
| 2023-06-15 | 개시 | BTIG Research | Buy |
| 2021-04-28 | 개시 | Truist | Buy |
| 2019-10-22 | 개시 | Oppenheimer | Outperform |
Beyond Air Inc 주식(XAIR)의 최신 뉴스
Geode Capital Management LLC Acquires 251,823 Shares of Beyond Air, Inc. (NASDAQ:XAIR) - Defense World
Beyond Air Inc (XAIR) Has Recovered 5.0% From Its Low: Is This The Beginning Of A Trend? - Stocksregister
Beyond Air Inc [XAIR] Records 200-Day SMA of $0.3963 - knoxdaily.com
Here is What to Know Beyond Why Alaska Air Group, Inc. (ALK) is a Trending Stock - Yahoo
A History of Outperforming Analyst Forecasts and Beating the Odds: Beyond Air Inc (XAIR) - Sete News
Two Months After Its Premiere, Beyond the Gates Is Off the Air: Why?!? - Soaps.com
Charting the Course: Beyond Air Inc’s XAIR Stock Prospects - investchronicle.com
Biosig Technologies Inc: Analyzing BSGM Stock Trends - investchronicle.com
Beyond Air Inc (XAIR) deserves deeper analysis - uspostnews.com
Why Isn't ‘Beyond the Gates’ on Today? - parade.com
An Analysis of Beyond Air Inc (XAIR)’s Potential Price Growth - knoxdaily.com
Lowe’s Cos., Inc [LOW] Stock bought by Insider Simkins Lawrence for $0.25 million - knoxdaily.com
Trading Day Triumph: Beyond Air Inc (XAIR) Ends at 0.22, a 3.67 Surge/Plunge - DWinneX
Crocs Inc [CROX] stock was sold by SISLER SHANNON at the price of US$0.51 million - knoxdaily.com
Potential Price Increase for Tenaris S.A. ADR (TS) After Recent Insider Activity - knoxdaily.com
Beyond Air granted U.S. patent for treatment of NTM infections using gaseous Nitric Oxide - MSN
Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO) - The Manila Times
Beyond Air (XAIR) Secures Patent for Novel Nitric Oxide Delivery Method | XAIR Stock News - GuruFocus
Beyond Air, Inc. Secures U.S. Patent for Novel Nitric Oxide Delivery Method in Treating NTM Lung Infections - Nasdaq
Beyond Air's Breakthrough: New Patent for At-Home NTM Treatment Could Transform Lung Care Through 2038 - Stock Titan
BTIG Research slashes price target on Beyond Air Inc [XAIR] – find out why. - dbtnews.com
Upward Trajectory: Beyond Air Inc (XAIR) Posts a Slidee, Closing at 0.23 - DWinneX
Shares In Beyond Air Inc (XAIR) -35.87% Down, YTD - Marketing Sentinel
Investing in ECARX Holdings Inc (ECX): What You Must Know - knoxdaily.com
XAIR’s price-to-free cash flow ratio: A closer look at its relevance - uspostnews.com
Does Beyond Air Inc (NASDAQ: XAIR) Still Look Hot This Week? - Stocksregister
Beyond Air Unit Receives Orphan Drug Designation for Prospective Phelan-McDermid Syndrome Treatment - marketscreener.com
NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism - The Manila Times
NeuroNOS Secures Exclusive FDA Orphan Drug Rights for Novel Autism-Related Disorder Treatment - Stock Titan
One Hour Heating & Air Conditioning honors local heroes in Hays County and beyond - Hays Free Press
NeuroNOS Appoints Dan Shechtman to Scientific Advisory Board - citybiz
Second Nobel Prize Winner Strengthens NeuroNOS Brain Disease Research Team - Stock Titan
Beyond Air (XAIR) Subsidiary Secures FDA Orphan Status for New T - GuruFocus
Beyond Air (XAIR) Subsidiary Secures FDA Orphan Status for New Treatment | XAIR Stock News - GuruFocus
BofA Slashes Delta Air Lines Estimates For 2025 And Beyond Amid Capacity, Revenue Challenges - Benzinga
Beyond Air Publishes Article in Annals of the American Thoracic - GuruFocus
Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients’ Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home - TradingView
Breakthrough: New Study Proves Patients Can Safely Self-Treat Severe Lung Disease at Home - Stock Titan
Stock Price Performance And Outlook Of Beyond Air Inc - Marketing Sentinel
Beyond Air, Inc. (XAIR) Reports Q3 Loss, Tops Revenue Estimates - MSN
Is it possible to buy Beyond Air Inc(XAIR) shares at a good price now? - uspostnews.com
Breakthrough: New Research Reveals Promising Early-Stage Alzheimer's Treatment Path - Stock Titan
Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site - The Manila Times
Major Medical Breakthrough: Vanderbilt Implements Beyond Air's Cylinder-Free Nitric Oxide Technology - Stock Titan
Beyond Air Inc (NASDAQ: XAIR) Has Dropped -81.35% So Far This Year. Does That Mean Trouble Ahead? - Marketing Sentinel
Neuronos raises funding to advance NO-regulating therapy for autism - BioWorld MedTech
Valeritas (OTCMKTS:VLRXQ) versus Beyond Air (NASDAQ:XAIR) Head-To-Head Analysis - Defense World
NeuroNOS Secures $2.0 Million in Funding - citybiz
Neuronos gets $2 mln funding for development of autism therapy -March 24, 2025 at 04:33 pm EDT - MarketScreener
NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy - The Manila Times
NeuroNOS Secures $2 Million in Funding - citybiz
Beyond Air Inc (XAIR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10.27%
0.14%
자본화:
|
볼륨(24시간):